Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T10:10:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    An NIH-wide notice explains the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    1.0%
    Check dated 2026-10-21T12:15:17.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T13:51:28.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.7.0' is added to the study record history, updating the version history. The previous revision 'Revision: v3.6.6' is removed from the current view.
    Difference
    0.1%
    Check dated 2026-09-16T21:53:30.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-02T18:09:38.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The record history now lists a new revision (v3.6.5) that supersedes the previous version (v3.6.4).
    Difference
    0.1%
    Check dated 2026-08-12T09:00:02.000Z thumbnail image

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.